Health
The drug aprotinin inhibits entry of SARS-CoV2 in host cells, study finds – Science Daily
In order for the SARS-CoV2 virus to enter host cells, its ‘spike’ protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin…
In order for the SARS-CoV2 virus to enter host cells, its “spike” protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin can prevent cell infection, as scientists at Goethe University, the University of Kent and the Hannover Medical School have now discovered. An aprotinin aerosol is already approved in Russia for the treatment of influenza and could readily be tested for the treatment of COVID-19.The surface of the SARS-CoV-2 virus is studded with spike…
-
Noosa News17 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News21 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News22 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General22 hours agoJim Chalmers will have to juggle competing demands to secure tax reform